is glp-1 safe for breast cancer survivors GLP-1s in Cancer: Overall Survival, Recurrence Risk, and Safety Efficacy of GLP-1 Receptor Agonists

Total disclosed investment in CDMO capacity: $24.86 billion, with 74% $18.48 billion flowing to the United States

The FDA-approved Wegovy prescribing information discloses that in the SELECT cardiovascular outcomes trial, hip and pelvis fractures occurred more often in female patients on Wegovy than on placebo (1% vs

In 2015, there were about 415 million patients with diabetes in the world, which is expected to increase to 642 million by 2040 ( Osteoporosis is a systemic bone disease characterized by a decrease in bone density, a reduction in bone mass, and an increase in bone fragility due to various reasons

B Shah V, et al

Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians

Experiencing physical discomfort driving her to binge, and then relief that the medication provided, Megan realized how much of her disorder was a biological condition, and not just a matter of discipline